225 related articles for article (PubMed ID: 31693175)
1. Treatment of acute leukaemia in adult Jehovah's Witnesses.
El Chaer F; Ballen KK
Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
[TBL] [Abstract][Full Text] [Related]
2. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
[TBL] [Abstract][Full Text] [Related]
3. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.
Tenenbaum T; Hasan C; Kramm CM; Janssen G; Laws HJ; Wessalowski R; Bode U; Göbel U
Onkologie; 2004 Apr; 27(2):131-7. PubMed ID: 15138344
[TBL] [Abstract][Full Text] [Related]
4. Justice and Respect for Autonomy: Jehovah's Witnesses and Kidney Transplant.
Cummins PJ; Nicoli F
J Clin Ethics; 2018; 29(4):305-312. PubMed ID: 30605440
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
Zhou L; Mohsen A; Khan MA; Guthrie T
J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.
Wilop S; Osieka R
Hematology; 2018 Jul; 23(6):324-329. PubMed ID: 29212421
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution.
Costanzo D; Bindi M; Ghinolfi D; Esposito M; Corradi F; Forfori F; De Simone P; De Gasperi A; Biancofiore G
BMC Anesthesiol; 2020 Jan; 20(1):31. PubMed ID: 32000668
[TBL] [Abstract][Full Text] [Related]
8. Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
Beck A; Lin R; Reza Rejali A; Rubens M; Paquette R; Vescio R; Merin N; Guerrero M; Federizo Y; Lua M; Uy L; Hernandez L; Allred M; Legaspi R; Leaverton M; Oliva S; Castillo R; Dean L; Bourke J; Cooper S; Gharapetian S; Causin J; Lopiccolo C; Ann Snoussi L; VanStrien P; Lill M; Linhares YP
Bone Marrow Transplant; 2020 Jun; 55(6):1059-1067. PubMed ID: 31898692
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of acute myeloid leukaemia without blood transfusion in a member of Jehovah's Witnesses].
Larsen C; Jensen MK
Ugeskr Laeger; 2011 Nov; 173(46):2960-2. PubMed ID: 22094219
[TBL] [Abstract][Full Text] [Related]
10. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.
Coltoff A; Shreenivas A; Afshar S; Steinberg A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):44-49. PubMed ID: 30605629
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Jehovah's Witnesses with hematological malignancies treated without transfusions - single center experience.
Drozd-Sokołowska JE; Waszczuk-Gajda A; Dwilewicz-Trojaczek J; Walesiak A; Krzyżanowska M; Paluszewska M; Wieczorek J; Jędrzejczak WW
Folia Med Cracov; 2020; 60(4):53-64. PubMed ID: 33821851
[TBL] [Abstract][Full Text] [Related]
12. Perioperative Jehovah's Witnesses: a review.
Lawson T; Ralph C
Br J Anaesth; 2015 Nov; 115(5):676-87. PubMed ID: 26068896
[TBL] [Abstract][Full Text] [Related]
13. Bloodless intensive care: a case series and review of Jehovah's Witnesses in ICU.
MacLaren G; Anderson M
Anaesth Intensive Care; 2004 Dec; 32(6):798-803. PubMed ID: 15648990
[TBL] [Abstract][Full Text] [Related]
14. ENT surgery, blood and Jehovah's Witnesses.
Woolley SL; Smith DR
J Laryngol Otol; 2007 May; 121(5):409-14. PubMed ID: 17125571
[TBL] [Abstract][Full Text] [Related]
15. The contemporary approach to the care of Jehovah's witnesses.
Hughes DB; Ullery BW; Barie PS
J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
[TBL] [Abstract][Full Text] [Related]
16. Children of Jehovah's Witnesses and adolescent Jehovah's Witnesses: what are their rights?
Woolley S
Arch Dis Child; 2005 Jul; 90(7):715-9. PubMed ID: 15970615
[TBL] [Abstract][Full Text] [Related]
17. Jehovah's Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies.
Park A; Rome S; Gantioque R
Clin J Oncol Nurs; 2019 Aug; 23(4):364-369. PubMed ID: 31322623
[TBL] [Abstract][Full Text] [Related]
18. Is There Sufficient Evidence Justifying Limited Access of Jehovah's Witness Patients to Kidney Transplantation?
Carvalho Fiel D; Nunes Ficher K; Bernardi Taddeo J; Linhares Silva K; Rosso Felipe C; Aguiar W; Daniel Braz Cardone J; Foresto RD; Tedesco-Silva H; Medina-Pestana J
Transplantation; 2021 Jan; 105(1):249-254. PubMed ID: 33350627
[TBL] [Abstract][Full Text] [Related]
19. A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem Cell Transplant.
Zhao JC; Arnall JR; Martin AL; Atrash S; Bhutani M; Voorhees P; Avalos B; Copelan E; Ghosh N; Hamadani M; Usmani S; Ford P
Biol Blood Marrow Transplant; 2019 Oct; 25(10):e305-e309. PubMed ID: 31295572
[TBL] [Abstract][Full Text] [Related]
20. Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.
Sagy I; Jotkowitz A; Barski L
J Relig Health; 2017 Apr; 56(2):732-738. PubMed ID: 28035631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
